Skip to main content
GENINCODE PLC logo

GENINCODE PLC — Investor Relations & Filings

Ticker · GENI ISIN · GB00BL97B504 LEI · 213800UX6TE7K65O2892 IL Professional, scientific and technical activities
Open in API
Filings indexed 111 across all filing types
Latest filing 2024-06-05 Report Publication Anno…
Country GB United Kingdom
Listing IL GENI

About GENINCODE PLC

https://genincode.com/

GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.

Recent filings

Filing Released Lang Actions
Posting of Annual Report and Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3440 characters) released via RNS (RNS Number : 2979R) on June 5, 2024. The title explicitly states: "Posting of Annual Report and Notice of Annual General Meeting". It confirms that the 'Annual Report and Accounts for the year ended 31 December 2023' and the 'Notice of Annual General Meeting ("AGM")' have been posted to shareholders and are available for download. According to Rule 2 (The "MENU VS MEAL" RULE), when a document is short and announces that a report (like the Annual Report or AGM notice) has been published or is attached/available for download, it should be classified as a Report Publication Announcement (RPA), not the report itself (10-K or AGM-R). Since this document's primary function is to announce the publication of the Annual Report and the AGM Notice, RPA is the most appropriate classification.
2024-06-05 English
Final Results
Earnings Release Classification · 1% confidence The document is an 'Earnings Release' (ER) because it is titled 'Final results' for the twelve months ended 31 December 2023, contains financial and operational highlights, management commentary, and forward-looking statements. It is not a full Annual Report (10-K) as it is a summary announcement of results, and it is not an RPA because it contains substantive financial data and performance metrics rather than just announcing the availability of a report. FY 2023
2024-06-03 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 5201P) on May 23, 2024. The core purpose of the announcement is to inform the market about the future release date of the audited final results for the year ended 31 December 2023 (scheduled for June 3, 2024) and to detail subsequent analyst and investor briefing/presentation schedules. Since the document itself is not the full financial report (10-K or IR) but rather an announcement *about* the upcoming release of results and associated events, it fits the definition of a Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because it has a more specific purpose related to scheduled results publication.
2024-05-23 English
CARDIO inCode-Score presentation
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 6995M' and is dated '01 May 2024'. It announces that GENinCode Plc will have a presentation at the European Society of Cardiology (ESC) Preventive Cardiology congress regarding their CARDIO inCode-Score®. The text describes scientific findings and the context of the presentation, but it is not the presentation itself, nor is it a full financial report (like 10-K or IR). The document structure, including the RNS header and the concluding boilerplate about RNS services, strongly indicates this is a regulatory news service announcement. Since the content is an announcement about scientific/clinical data being presented, and it is distributed via RNS, it fits best under the general 'Regulatory Filings' category (RNS) as a specific announcement, rather than a dedicated financial report type. It is not a Call Transcript (CT), Earnings Release (ER), or Investor Presentation (IP), but rather a news item about an upcoming event/data release.
2024-05-01 English
Grant of Options & Surrender of Existing Options
Director's Dealing Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 2623M' and the closing footer referencing RNS/LSE). The content explicitly details the 'Grant of Share Options, Surrender of Existing Options & PDMR Dealings' for directors and employees. This type of filing, which reports personal share transactions by company directors and executives (insider trades) under MAR regulations, directly corresponds to the 'Director's Dealing' category. Although it is an RNS announcement, the specific content is highly indicative of DIRS, which takes precedence over the general RNS fallback.
2024-04-26 English
CARDIO inCode-Score® US study publication
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 3406J' and contains standard regulatory boilerplate language at the end, including references to 'RNS, the news service of the London Stock Exchange' and FCA approval. This strongly indicates a regulatory announcement disseminated via the RNS system. The content itself is an announcement about a clinical study publication regarding the company's CARDIO inCode-Score product, which is a form of corporate news release. Since it is a general regulatory announcement that doesn't fit the specific categories like Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing category, RNS.
2024-04-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.